一个竞争性抑制剂将 LeuT 陷入一个开放式的外形结构中
Satinder K Singh1, Chayne L Piscitelli, Atsuko Yamashita
1Vollum Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.
概括
二级转运器可以将分子移动穿过膜. 关于氨酸载体 (LeuT) 的研究揭示了基质如何引起构造变化,以及托 (Trp) 等抑制剂如何通过在开放状态下捕获载体来阻止运输.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 膜运输 运输 膜运输
背景情况:
- 二级载体是关键的膜蛋白,促进分子和离子在细胞双层之间运输.
- 了解这些载体的动态形状变化,运输机制和竞争性抑制是必不可少的,但仍然具有挑战性.
研究的目的:
- 为了阐明二次输送器中基质运输过程中的形状变化.
- 通过使用氨酸载体 (LeuT) 作为模型系统,研究竞争性抑制的机制.
主要方法:
- 结晶学研究被用来确定 LeuT 与基质和抑制剂复合的结构.
- 进行了功能性测试,以评估LeuT的运输活动和构造状态.
主要成果:
- 发现各种氨基酸基质在LeuT.中诱导了类似的封闭形态状态.
- 观察到竞争性抑制剂酸 (Trp) 将 LeuT 陷入一个开放式的外形.
- 确定了涉及细胞外门残留物 (Arg30和Asp404) 的二次结合部位,介导抑制剂/基质透.
结论:
- 这项研究揭示了 LeuT.中基质和抑制剂诱导的独特的构造状态.
- 鉴定到的二次结合部位突出显示了网关残留物在基板透和输送器调节中的双重作用.
- 这些发现提供了关于神经递质同载体的传输机制和竞争性抑制的见解.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...


